Soleus Capital Management, L.P. Surmodics Inc Transaction History
Soleus Capital Management, L.P.
- $1.29 Billion
- Q2 2025
A detailed history of Soleus Capital Management, L.P. transactions in Surmodics Inc stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 789,060 shares of SRDX stock, worth $29.9 Million. This represents 1.82% of its overall portfolio holdings.
Number of Shares
789,060
Previous 789,060
-0.0%
Holding current value
$29.9 Million
Previous $24.1 Million
2.69%
% of portfolio
1.82%
Previous 1.99%
Shares
20 transactions
Others Institutions Holding SRDX
# of Institutions
144Shares Held
12.5MCall Options Held
103KPut Options Held
212K-
Black Rock Inc. New York, NY1.17MShares$44.4 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY850KShares$32.2 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA810KShares$30.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY656KShares$24.9 Million0.0% of portfolio
-
Readystate Asset Management LP Chicago, IL434KShares$16.4 Million0.39% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $531M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...